Deracoxib (trade name Deramaxx Novartis) is a non-steroidal anti-inflammatory drug of the coxib class used in veterinary medicine to treat osteoarthritis in dogs. It is sold in tablets which have added beefy flavor to increase palatability. Deramaxx received FDA approval in August 2002 for the control of post operative pain and inflammation associated with orthopedic surgery in dogs.
This page contains content from the copyrighted Wikipedia article "Deracoxib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
